MiniMed Group, Inc. (MMED)

Chart not available yet

Data will show when the stock starts trading on Mar 5, 2026.

Market Cap	7.44B
Revenue (ttm)	2.89B +10.0%
Net Income	-211.00M
EPS	-0.75
Shares Out	280.81M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About MMED

MiniMed Group is a scaled global medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Since our founding more than 40 years ago, we have pioneered groundbreaking innovation and served the needs of our customers across the globe in service of our mission to make every day a better day for people with diabetes. We address this market by offering various diabetes technologies, including insulin delivery devices (primarily insulin pumps and pens), continuous glucose m...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Mar 5, 2026
• Employees: 8,000
• Stock Exchange: NASDAQ
• Ticker Symbol: MMED
• Website: https://www.medtronicdiabetes.com/

Financial Performance

In fiscal year 2025, MiniMed Group's revenue was $2.72 billion, an increase of 9.96% compared to the previous year's $2.47 billion. Losses were -$213.00 million, 90.2% more than in 2024.